Population modelling of nilotinib exposure vs . longitudinal BCR::ABL1 response in patients with chronic phase chronic myeloid leukaemia using a semimechanistic disease model

Documenti analoghi

• Corrigendum to “Histone demethylase PHF8 facilitates the development of chronic myeloid leukaemia by directly targeting BCR::ABL1 ”
  Pubblicazione: (2024)
• The Mozart effect in chronic myeloid leukaemia
  di: Jesper Stentoft
  Pubblicazione: (2024)
• An old leukaemia in young patients—Genetic characteristics of paediatric chronic myeloid leukaemia
  di: Markus Metzler, et al.
  Pubblicazione: (2025)
• Introducing a prognostic score for successful treatment‐free remission in chronic myeloid leukaemia
  di: Simone Claudiani, et al.
  Pubblicazione: (2026)
• Outcomes following exposure to drug interactions with ibrutinib in patients with chronic lymphocytic leukaemia
  di: Tuan Hoang, et al.
  Pubblicazione: (2025)